PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 178 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2018. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $1,000 | -75.0% | 7 | -80.6% | 0.00% | -80.0% |
Q3 2017 | $4,000 | -99.1% | 36 | -99.3% | 0.01% | -97.9% |
Q2 2017 | $459,000 | -72.5% | 5,246 | -78.9% | 0.23% | -60.7% |
Q3 2016 | $1,670,000 | +3308.2% | 24,906 | +11990.3% | 0.60% | +2188.5% |
Q3 2014 | $49,000 | – | 206 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 1,417,000 | $18,010,000 | 2.24% |
Palo Alto Investors LP | 1,405,680 | $17,866,000 | 0.87% |
PFM Health Sciences, LP | 2,838,376 | $36,076,000 | 0.68% |
TANG CAPITAL MANAGEMENT LLC | 349,400 | $4,441,000 | 0.60% |
Capital Impact Advisors, LLC | 127,029 | $1,615,000 | 0.59% |
Leap Investments LP | 29,100 | $370,000 | 0.50% |
Spark Investment Management LLC | 454,300 | $5,774,000 | 0.40% |
Partner Investment Management, L.P. | 27,567 | $350,000 | 0.37% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 262,945 | $3,342,000 | 0.26% |
Rock Springs Capital Management LP | 534,400 | $6,792,000 | 0.25% |